ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
ABEO on Nasdaq
Shares outstanding
53,583,544
Price per share
$5.27
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
35,587,405
Total reported value
$187,905,228
% of total 13F portfolios
0%
Share change
+806,489
Value change
+$3,962,019
Number of holders
99
Price from insider filings
$5.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Adage Capital Management, L.P. 10% +13% $28,263,819 +$4,970,719 5,352,996 +21% Adage Capital Management, L.P. 30 Sep 2025
Nantahala Capital Management, LLC 10% 0% $27,327,316 +$988,597 5,184,662 +3.8% Nantahala Capital Management, LLC 30 Sep 2025
BlackRock, Inc. 5.8% $16,751,808 2,949,262 BlackRock, Inc. 30 Jun 2025
James Russell Revocable Trust 5.3% $18,774,038 2,720,875 James Russell Revocable Trust 16 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.2% $15,627,840 2,676,000 Suvretta Capital Management, LLC 30 Jun 2025
Nantahala Capital Partners Limited Partnership 5.1% $13,801,390 2,618,462 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 29 Sep 2025
VANGUARD GROUP INC 5.1% $13,741,756 2,602,901 The Vanguard Group 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 1.7% $4,292,820 809,966 Millennium Management LLC 31 Mar 2025

As of 30 Sep 2025, 99 institutional investors reported holding 35,587,405 shares of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO). This represents 66% of the company’s total 53,583,544 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 8.5% 4,564,665 +4.5% 1.5% $24,101,431
BlackRock, Inc. 5.9% 3,147,150 +4.9% 0% $16,616,951
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.7% 3,047,985 -0.81% 0.03% $16,093,361
SUVRETTA CAPITAL MANAGEMENT, LLC 5% 2,676,000 0% 0.43% $14,129,280
VANGUARD GROUP INC 4.9% 2,602,901 +3.8% 0% $13,743,318
Vivo Capital, LLC 3.4% 1,842,751 0% 0.78% $9,729,725
Western Standard LLC 2.3% 1,249,957 -40% 3.5% $6,599,773
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,127,131 +1.9% 0% $5,952,529
KENNEDY CAPITAL MANAGEMENT LLC 2% 1,050,863 +56% 0.12% $5,548,557
SILVERARC CAPITAL MANAGEMENT, LLC 1.9% 994,754 +8.4% 0.76% $5,252,301
Propel Bio Management, LLC 1.8% 974,022 0% 5.1% $5,142,836
BANK OF AMERICA CORP /DE/ 1.7% 912,912 +177% 0% $4,820,175
683 Capital Management, LLC 1.4% 770,000 +2.7% 0.37% $4,065,600
STATE STREET CORP 1.3% 716,154 +22% 0% $3,781,293
MILLENNIUM MANAGEMENT LLC 1.3% 709,349 +176% 0% $3,745,363
MORGAN STANLEY 1.1% 607,641 -37% 0% $3,208,344
Cable Car Capital, LP 1.1% 600,000 1.4% $3,168,000
Simplify Asset Management Inc. 1.1% 565,009 +1.2% 0.06% $2,983,248
NAN FUNG TRINITY (HK) LTD 1% 560,770 0% 0.3% $2,960,866
AWM Investment Company, Inc. 1% 547,000 +16% 0.27% $2,888,160
RENAISSANCE TECHNOLOGIES LLC 0.98% 526,437 +76% 0% $2,779,587
CITIGROUP INC 0.98% 523,956 -4.4% 0% $2,766,489
BOONE CAPITAL MANAGEMENT LLC 0.94% 502,854 -60% 0.87% $2,655,069
Stonepine Capital Management, LLC 0.84% 450,970 +902% 1.9% $2,381,122
NORTHERN TRUST CORP 0.79% 422,227 -2.8% 0% $2,229,358

Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 627,260 $3,306,108 +$3,301,426 $5.27 4
2025 Q3 35,587,405 $187,905,228 +$3,962,019 $5.28 99
2025 Q2 34,902,859 $198,249,797 +$32,047,638 $5.68 95
2025 Q1 29,672,466 $141,241,182 -$4,440,489 $4.76 70
2024 Q4 30,594,457 $170,412,284 +$10,328,621 $5.57 62
2024 Q3 28,750,213 $181,703,500 -$8,991,871 $6.32 54
2024 Q2 30,142,466 $127,804,658 +$64,543,759 $4.24 47
2024 Q1 14,448,596 $104,749,937 +$6,931,452 $7.25 55
2023 Q4 14,140,688 $70,843,546 +$8,490,638 $5.01 48
2023 Q3 12,477,026 $52,529,560 +$13,131,838 $4.21 38
2023 Q2 9,392,092 $37,850,403 +$7,730,751 $4.03 36
2023 Q1 7,525,889 $21,222,791 -$5,713,208 $2.82 33
2022 Q4 7,901,310 $24,332,329 +$21,133,266 $3.08 38
2022 Q3 1,039,522 $3,159,012 +$3,053,000 $3.04 19
2022 Q2 34,773 $169,000 +$169,000 $4.86 1